Literature DB >> 8054270

Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells.

L Bao1, Y Matsumura, D Baban, Y Sun, D Tarin.   

Abstract

The co-injection of extracellular matrix components, such as Matrigel, with human tumour cells into nude mice has been reported to facilitate tumour formation and growth, but it is unknown whether such components exert similar effects on tumour progression and metastasis. Metastatic behaviour is known to be enhanced when tumour cells are implanted orthotopically, and it is inferred that full and efficient expression of this phenotype may involve some interactions with local connective tissue matrix. It was therefore decided to investigate whether manipulation of the mesenchymal environment by co-injection of extracellular matrix components, in the form of Matrigel, with human breast cancer cells into orthotopic or ectopic sites could augment their metastatic performance, as well as their growth at the site of inoculation. Standard aliquots of 10(6) cells of the polyclonal human breast carcinoma cell line MDA-MB-435, and of four clonal cell lines, two metastatic and two non-metastatic derived from it, were injected with and without Matrigel, orthotopically or subcutaneously into nude mice. The latent period of tumour formation at the inoculation site as well as final tumour size and metastatic performance at autopsy, 140 days after inoculation, were then assessed. The prevalence of metastasis of the parent, polyclonal, cell line and of its metastatic clones was increased if the cell inoculum was mixed with Matrigel. Non-metastatic clones were not induced to become metastatic by this treatment, but local tumour growth at the site of inoculation was enhanced in all experimental groups receiving Matrigel. Orthotopic inoculation acted synergistically with Matrigel to maximise both tumour growth and metastatic behaviour. The composition of the local extracellular matrix at the site of tumour growth influenced expression of the metastatic phenotype by cells which are constitutionally capable of this behaviour, but did not induce it in ones which are not. Previous reports that local tumour growth is facilitated by enrichment of the mesenchymal matrix are confirmed. The mechanisms by which such effects are exerted are worthy of study, to ascertain whether they might be subject to clinical manipulation designed to retard tumour growth and dissemination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054270      PMCID: PMC2033496          DOI: 10.1038/bjc.1994.284

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

2.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

3.  Transplantation of human prostatic carcinoma into nude mice in Matrigel.

Authors:  T G Pretlow; C M Delmoro; G G Dilley; C G Spadafora; T P Pretlow
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

4.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.

Authors:  R Fridman; G Giaccone; T Kanemoto; G R Martin; A F Gazdar; J L Mulshine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

Review 7.  Tumor heterogeneity and the biology of cancer invasion and metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

8.  Transfection of metastatic capability with total genomic DNA from human and mouse metastatic tumour cell lines.

Authors:  A J Hayle; D L Darling; A R Taylor; D Tarin
Journal:  Differentiation       Date:  1993-10       Impact factor: 3.880

9.  Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice.

Authors:  A Fabra; M Nakajima; C D Bucana; I J Fidler
Journal:  Differentiation       Date:  1992-12       Impact factor: 3.880

10.  Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel).

Authors:  R Fridman; T M Sweeney; M Zain; G R Martin; H K Kleinman
Journal:  Int J Cancer       Date:  1992-07-09       Impact factor: 7.396

View more
  22 in total

1.  Optically imageable metastatic model of human breast cancer.

Authors:  Xiaoming Li; Jinwei Wang; Zili An; Meng Yang; Eugene Baranov; Ping Jiang; Fangxian Sun; A R Moossa; Robert M Hoffman
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Isolation of mammary-specific extracellular matrix to assess acute cell-ECM interactions in 3D culture.

Authors:  Jenean O'Brien; Jaime Fornetti; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-03       Impact factor: 2.673

3.  Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection.

Authors:  Rafael Fridman; Gabriel Benton; Irina Aranoutova; Hynda K Kleinman; R Daniel Bonfil
Journal:  Nat Protoc       Date:  2012-05-17       Impact factor: 13.491

Review 4.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  Thymosin beta15 expression in tumor cell lines with varying metastatic potential.

Authors:  L Bao; M Loda; B R Zetter
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

6.  Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.

Authors:  Yoshihiro Koya; Hiroaki Kajiyama; Wenting Liu; Kiyosumi Shibata; Takeshi Senga; Fumitaka Kikkawa
Journal:  J Vis Exp       Date:  2016-12-09       Impact factor: 1.355

7.  Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth.

Authors:  Begüm Kocatürk; Henri H Versteeg
Journal:  J Vis Exp       Date:  2015-02-08       Impact factor: 1.355

8.  Microencapsulated tumor assay: evaluation of the nude mouse model of pancreatic cancer.

Authors:  Ming-Zhe Ma; Dong-Feng Cheng; Jin-Hua Ye; Yong Zhou; Jia-Xiang Wang; Min-Min Shi; Bao-San Han; Cheng-Hong Peng
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

9.  Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.

Authors:  Yoshinori Kato; Wenlian Zhu; Marina V Backer; Christopher C Neoh; Sudath Hapuarachchige; Susanta K Sarkar; Joseph M Backer; Dmitri Artemov
Journal:  Pharm Res       Date:  2015-06-16       Impact factor: 4.200

10.  Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.

Authors:  Mika Suzuki; Evangeline Mose; Christine Galloy; David Tarin
Journal:  Am J Pathol       Date:  2007-07-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.